NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Monday, June 1, 2015, at 7 p.m. EDT (6 p.m. CDT) to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Â
Company executives will provide an overview of data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com, by dialing U.S. toll-free (877) 201-0168 or international (647) 788-4901, confirmation code: 4580465. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 10:30 p.m. EDT on June 1 through 11:59 p.m. EDT on June 8. The replay can be accessed at http://investor.bms.com or by dialing (855) 859-2056, confirmation code: 4580465.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Contact:
Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Ranya Dajani, 609-252-5330
ranya.dajani@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com
Â
Â
